Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19.7M
-
Number of holders
-
263
-
Total 13F shares, excl. options
-
24.7M
-
Shares change
-
-223K
-
Total reported value, excl. options
-
$2.94B
-
Value change
-
-$22.6M
-
Put/Call ratio
-
2.37
-
Number of buys
-
145
-
Number of sells
-
-110
-
Price
-
$119.27
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2016
296 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q2 2016.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 263 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.7M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1.52M shares), BlackRock Fund Advisors (1.47M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.26M shares), Knott David M (1.2M shares), FMR LLC (1.06M shares), OAK RIDGE INVESTMENTS LLC (868K shares), RS INVESTMENT MANAGEMENT CO LLC (825K shares), WELLS FARGO & COMPANY/MN (780K shares), STATE STREET CORP (737K shares), and CARDINAL CAPITAL MANAGEMENT LLC /CT (669K shares).
This table shows the top 263 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.